January 6, 2017 / 1:13 PM / 7 months ago

BRIEF-Momenta provides year-end 2016 corporate update

1 Min Read

Jan 6 (Reuters) - Momenta Pharmaceuticals Inc :

* Momenta provides year-end 2016 corporate update

* Momenta Pharmaceuticals Inc - reiterated its non-gaap operating expense guidance of approximately $40 - $45 million for Q4 of 2016

* Momenta Pharmaceuticals Inc - expects to report approximately $350.0 million of cash, cash equivalents and marketable securities at December 31, 2016

* Momenta Pharmaceuticals Inc - currently assessing U.S. Gaap accounting treatment for shire and csl agreements Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below